Alphamab Oncology (HKG:9966)
Hong Kong · Delayed Price · Currency is HKD 9.42
-0.43 (-4.37%)
May 27, 2026, 4:09 PM HKT
Alphamab Oncology Stock Forecast
Stock Price Forecast
The 2 analysts that cover Alphamab Oncology stock have a consensus rating of "Buy" and an average price target of $11.95, which forecasts a 26.86% increase in the stock price over the next year. The lowest target is $9.60 and the highest is $14.30.
Price Target: $11.95 (+26.86%)
Analyst Consensus: Buy
* Price targets were last updated on Mar 27, 2026.
Analyst Ratings
The average analyst rating for Alphamab Oncology stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Sep '25 | Nov '25 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains $9.60 | Buy | Maintains | $9.60 | +1.91% | Mar 27, 2026 |
Unknown Analyst Sinolink Securities No rating | Sinolink Securities | Buy Maintains $14.30 | Buy | Maintains | $14.30 | +51.80% | Dec 21, 2025 |
Unknown Analyst BOCOM International Holdings Company No rating | BOCOM International Holdings Company | Buy Maintains $13.00 | Buy | Maintains | $13.00 | +38.00% | Dec 14, 2025 |
Sources: Price targets and consensus ratings provided by TipRanks. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.